First human trial tests new cell therapy for devastating autoimmune diseases

NCT ID NCT06308978

Recruiting now Disease control Sponsor: Fate Therapeutics Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety of an experimental cell therapy called FT819 for four serious autoimmune diseases: lupus, vasculitis, myositis, and scleroderma. Researchers will give FT819 to 244 participants aged 12-70 who have moderate to severe disease that hasn't responded well to at least two prior treatments. The main goal is to find a safe dose and see how the body handles the treatment, while also checking if it helps control disease activity.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cambridge University Hospitals NHS Foundation Trust
RECRUITING

Cambridge, CB2 0QQ, United Kingdom
Children's Hospital Los Angeles Division Of Rheumatology
RECRUITING

Los Angeles, California, 90027, United States
Duke University Health System
RECRUITING

Durham, North Carolina, 27705, United States
Hôpital La Pitié Salpêtrière
RECRUITING

Paris, 75013, France
Jefferson Einstein Hospital Philadelphia
RECRUITING

Philadelphia, Pennsylvania, 19141, United States
Manchester University NHS Foundation Trust
RECRUITING

Manchester, Greater Manchester, M139WL, United Kingdom
MetroHealth
RECRUITING

Cleveland, Ohio, 44109, United States
Montefiore Medical Center
RECRUITING

New York, New York, 10467, United States
Providence Medical Foundation
RECRUITING

Fullerton, California, 92835, United States
Regional One Health
RECRUITING

Memphis, Tennessee, 38103, United States
University College of London Hospitals NHS Trust (UCLH)
RECRUITING

London, NW1 2PQ, United Kingdom
University of California Irvine
RECRUITING

Irvine, California, 92868, United States
University of California San Francisco
RECRUITING

San Francisco, California, 94110, United States
University of Minnesota Medical School
RECRUITING

Minneapolis, Minnesota, 55455, United States
University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States
University of Oklahoma
RECRUITING

Oklahoma City, Oklahoma, 73019, United States
Uppsala University
RECRUITING

Uppsala, Uppland, 752 37, Sweden

Conditions

Explore the condition pages connected to this study.

ANTINEUTROPHILIC CYTOPLASMIC ANTIBODY (ANCA)- ASSOCIATED VASCULITIS (AAV) IDIOPATHIC INFLAMMATORY MYOSITIS (IIM) SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) SYSTEMIC SCLEROSIS (SSC)